Ambac Financial Group, Inc. 2016 Second-Quarter Form 10-Q Summary
Filing identity: The request metadata identifies “OCTAVE SPECIALTY GROUP INC,” but the supplied filing is for Ambac Financial Group, Inc. and its subsidiaries. The filing covers the quarter and six months ended June 30, 2016; financial statements are unaudited and prepared under U.S. GAAP.
Business context and reporting period
Ambac is a financial services holding company with Financial Guarantee and Financial Services segments. Its insurance operations are in active runoff; Ambac Assurance has been unable to write new financial guarantee business since the deterioration of its insured portfolio. The company is subject to Segregated Account rehabilitation proceedings in Wisconsin and states that there is substantial doubt about its ability to continue as a going concern, although the financial statements were prepared on a going-concern basis.
At June 30, 2016, total insured net par exposure was $94.4 billion, including $56.4 billion of public finance, $19.0 billion of structured finance and $18.9 billion of international finance exposure. Below-investment-grade exposure was $17.8 billion.
Key financial metrics
| Metric | Three months ended June 30, 2016 | Six months ended June 30, 2016 |
|---|---|---|
| Net premiums earned | $41.4 million | $94.2 million |
| Net investment income | $70.8 million | $131.6 million |
| Total revenues | $106.7 million | $123.6 million |
| Loss and loss expense benefit | $52.5 million | $157.8 million |
| Derivative product revenues/(losses) | $(36.3) million | $(119.8) million |
| Pre-tax income | $61.5 million | $74.4 million |
| Net income attributable to common stockholders | $58.6 million | $68.1 million |
| Diluted earnings per share | $1.29 | $1.50 |
| Operating earnings, non-GAAP | $115.0 million | $333.2 million |
- Total assets were $23.2 billion versus $23.7 billion at December 31, 2015.
- Total liabilities were $21.1 billion versus $21.8 billion at year-end 2015.
- Total stockholders’ equity was $2.1 billion versus $2.0 billion at year-end 2015; Ambac Financial Group common stockholders’ equity was $1.8 billion.
- Investments totaled $6.5 billion, including $5.7 billion of fixed-income securities and $336.2 million of short-term investments.
- Cash and cash equivalents were $23.0 million, compared with $35.7 million at December 31, 2015. Management reported corporate liquidity of $217.0 million in cash and liquid investments.
- Long-term debt was $1.1 billion, excluding $11.4 billion of consolidated VIE debt. Accrued interest on surplus notes and junior surplus notes totaled $384.7 million.
- Net cash provided by operating activities was $870.3 million; investing activities used $830.2 million and financing activities used $52.8 million, producing a $12.7 million decline in cash.
Material changes versus prior comparable periods
- Second-quarter net income attributable to common stockholders declined to $58.6 million from $282.7 million; first-half net income declined to $68.1 million from $497.4 million.
- Net premiums earned declined 32% in the quarter and 26% year to date, primarily due to portfolio runoff and lower accelerated premiums.
- Derivative product results changed from gains of $51.0 million in the second quarter of 2015 and $13.2 million in the first half of 2015 to losses of $36.3 million and $119.8 million, respectively, primarily because forward interest rates declined in 2016.
- Income from consolidated variable interest entities declined to $9.0 million in the quarter from $52.6 million and changed to a first-half loss of $18.2 million from income of $59.6 million.
- The loss and loss expense benefit decreased to $52.5 million in the quarter and $157.8 million year to date, versus benefits of $147.5 million and $298.4 million in the comparable 2015 periods.
- Operating cash flow benefited from approximately $992.8 million of net proceeds from a January 2016 settlement with JPMorgan related to RMBS representation-and-warranty claims and $99.1 million of Countrywide settlement recoveries.
- Insured net par exposure declined by $13.9 billion, or 13%, from year-end 2015. Commutations, cancellations, calls, refundings, scheduled paydowns and foreign-exchange movements were the primary drivers.
- Gross loss and loss expense reserves increased to $4.3 billion from $4.1 billion, while subrogation recoverable declined to $677.2 million from $1.2 billion, largely reflecting settlement collections.
- Accumulated other comprehensive income increased to $50.8 million from $15.2 million, principally from unrealized investment gains, partially offset by foreign-currency translation losses.
Guidance, outlook, risks and unusual items
- No formal earnings or financial guidance is provided. Management expects continued runoff, policy commutations, settlements, recoveries and active asset/liability management.
- Ambac Assurance’s policyholder surplus was $754.6 million, above the $100 million minimum surplus amount required for payments under certain agreements. Dividend payments from Ambac Assurance to the holding company are considered highly unlikely for the foreseeable future.
- The company is evaluating possible transactions to monetize assets and restructure or exchange debt and insurance obligations to support an exit from rehabilitation. No agreement had been reached as of the filing date, and any transaction would require regulatory and court approvals.
- Management disclosed substantial doubt about the company’s ability to continue as a going concern. Liquidity depends on cash and investments, expense-sharing arrangements and potential tax tolling payments; contingencies could materially strain liquidity.
- Puerto Rico is a major risk: Ambac had approximately $2.2 billion of exposure, and Puerto Rico defaulted on approximately $0.9 billion of debt service due July 1, 2016. PROMESA and related restructuring and litigation stays create significant uncertainty.
- Management identified potential reserve sensitivity of approximately $1.98 billion for RMBS if recorded representation-and-warranty recoveries were not realized, approximately $137 million for student loans and approximately $1.16 billion for public finance exposures under identified stress scenarios.
- Brexit reduced the value of Ambac’s foreign-currency assets and liabilities and contributed to approximately $65 million of adverse second-quarter comprehensive-income impact, primarily through translation losses.
- Ambac UK reported a £124.0 million Solvency II capital-resources deficit as of March 31, 2016, compared with a £371.3 million regulatory capital requirement. June 30 information was not yet finalized as of the filing.
- Disclosure controls and procedures were deemed ineffective because of a previously identified material weakness involving modeling of RMBS collateral losses. Management expected remediation by December 31, 2016.
- A putative securities class action was filed in June 2016 alleging misleading disclosures concerning risk management, controls, credit mitigation and Puerto Rico exposure. Management believes the action is without merit.
Important facts for investors to verify
- Confirm that the intended issuer is Ambac Financial Group rather than the company identified in the request metadata.
- Review the going-concern disclosure and the company’s actual parent-level liquidity, including restrictions on dividends from Ambac Assurance.
- Assess Puerto Rico exposure, PROMESA developments, claim payments and potential reserve changes.
- Evaluate the collectability and valuation sensitivity of approximately $1.9 billion of recorded RMBS representation-and-warranty recoveries.
- Review Ambac UK’s finalized June 30, 2016 Solvency II capital position and regulator discussions.
- Consider the effect of interest rates, foreign exchange, credit spreads, VIE fair values and collateral requirements on future earnings and liquidity.
- Monitor remediation of the RMBS modeling material weakness and developments in the securities class action and other litigation.
- Distinguish GAAP net income from non-GAAP operating earnings and adjusted book value, which were $333.2 million and $1.35 billion, respectively, for the relevant first-half or period-end measures.